It was 2001 and Graham Richards, Ph.D., a scientist funded from 1982 to 2007 by the National Foundation for Cancer Research, was faced with a challenge: How to harness the power of a supercomputer for virtual cancer drug models when you have neither the budget nor the space required? The…...